Lanthanum Chewable Tablets and Mogamulizumab-kpkc Intravenous
Determining the interaction of Lanthanum Chewable Tablets and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanthanum carbonate
Brand name: Fosrenol
Synonyms: Lanthanum carbonate, Lanthanum
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanthanum Chewable Tablets-Molindone
- Lanthanum Chewable Tablets-Mometasone (Oral Inhalation)
- Lanthanum Chewable Tablets-Mometasone and Formoterol
- Lanthanum Chewable Tablets-Mometasone and formoterol Inhalation
- Lanthanum Chewable Tablets-Mometasone Cream
- Lanthanum Chewable Tablets-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Lanthanum Powder
- Mogamulizumab-kpkc Intravenous-Lantus
- Mogamulizumab-kpkc Intravenous-Lantus SoloStar
- Mogamulizumab-kpkc Intravenous-Lantus SoloStar (Insulin Glargine (U-100) Cartridge Systems and Pens)
- Mogamulizumab-kpkc Intravenous-Lantus Solostar (Insulin Glargine (U-300) Pens)
- Mogamulizumab-kpkc Intravenous-Lantus Solostar Pen